Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Phenylbutazone 100mg tablets
1001010Q0AAABAB
|
Phenylbutazone | Phenylbutazone | Musculoskeletal and Joint Diseases | 12 |
|
Butacote 100mg gastro-resistant tablets
1001010Q0BBAAAB
|
Butacote | Phenylbutazone | Musculoskeletal and Joint Diseases | No data available |
|
Phenylbutazone 200mg tablets
1001010Q0AAACAC
|
Phenylbutazone | Phenylbutazone | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.